Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bard Memotherm

This article was originally published in The Gray Sheet

Executive Summary

Colorectal stent gains 510(k) clearance for treating malignant obstructions resulting from colon cancer. The self-expanding nitinol device is preloaded on a flexible delivery catheter and endoscopically placed into the colon as a minimally invasive alternative to multi-staged surgery with colostomy to manage patients with bowel obstruction due to malignant growths and strictures. The stent can be used for elective placement to decompress the colon and optimize a patient's condition prior to surgery or for palliative use to avoid colostomy in patients who are not surgical candidates
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT013292

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel